SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Tunica Albuginea who wrote (5508)2/18/1998 5:42:00 PM
From: Colby  Respond to of 23519
 
Some more conspiracy theory (I think),
From the seX -files:

Today on one of the morning shows, sources who witnessed the matter think it was Good Morning America, although this has not been verified, ran a show about Male menopause. They went on to discuss ED and the cure-all pill. No mention of VVUS or nothing.
Now, if it was NBC who ran this show, that would be their third anti-VVUS effort . One was the news article which, again, promoted PFE and degraded VVUS, the Superbowl fiasco (which was a blessing) and now this. Does GE own a lot of PFE's stock or what?

The above mentioned is not necessarily the opinion of the author, although he doth thinkest some coincidences exist.

Also, the PFE marketing group has done a fantastic job. Here they have a pill not even approved which seems at best to be an erection "enhancer" and people are calling the cure for ED in a pill. VVUS is the company with that thing you stick inside your penis. This stock will do very little to the upside until MCA approval comes, if it does. We could see that in the next two weeks. That should give us a tremendous boost.

Standing erect,
Colby



To: Tunica Albuginea who wrote (5508)2/18/1998 9:22:00 PM
From: John J H Kim  Read Replies (1) | Respond to of 23519
 
We all, you especially know a lot of the fundamentals, the technicals, the good, the bad the ugly of VVUS. Now it is time to listen to the tape to tell it's story.